![j plus](/www.thejakartapost.com/skin/img/jplus/logo.png)
![](/3dwnh01icn0h133s00sokwo1-wpengine.netdna-ssl.com/wp-content/uploads/2016/03/knh1-120x90.jpg)
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust. .
-
.
-
.
.
the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate".
OFF DEAL
OFF DEAL
181 Used Today